v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue $ 0 $ 93,549
Cost of revenue 235,717 856,956
Gross margin (235,717) (763,407)
Operating expenses:    
Research and development 184,563 766,495
Selling and marketing 543,337 345,590
General and administrative 2,078,805 2,652,795
Total operating expenses 2,806,705 3,764,880
Loss from operations (3,042,422) (4,528,287)
Non-operating expenses:    
Interest income 7,385 11,740
Interest expense (193,480) (1,191,862)
Change in fair value of warrant liabilities 127,300 3,311
Change in fair value of derivative liability 37,900 0
Change in fair value of debt 256,522 0
Loss on issuance of debt (707,800) 0
Loss on extinguishment of debt (5,497,516) 0
Gain on sale of intellectual property intangible assets 8,961,872 0
Loss on impairment of inventories, property and equipment and operating lease right-of-use asset (6,064,823) 0
Interest expense recognized on remeasurement of preferred stock liability (10,398,050) 0
Other loss, net (98,313) 0
Loss before provision for income taxes (16,611,425) (5,705,098)
Provision for income taxes 0 0
Net loss (16,611,425) (5,705,098)
Reclassification of convertible preferred stock from mezzanine equity to liability 10,398,050 0
Deemed dividend in connection with modification of pre-funded warrants (3,076,380) 0
Net loss available to common shareholders $ (9,289,755) $ (5,705,098)
Net loss per common share, basic $ (0.28) $ (6.18)
Net loss per common share, diluted $ (0.28) $ (6.18)
Weighted-average common shares used to compute net loss per common share, basic 33,074,691 922,894
Weighted-average common shares used to compute net loss per common share, diluted 33,074,691 922,894